Litao Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Litao Xie has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Rajan Sah
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
3 shared publications - Yonghui Zhao
Department of Internal Medicine, Cardiovascular Division (Q.Y., Y.Z., J.M., P.A., N.J., J.D.T., T.M.A.E.-A., M.R., R.S.), Washington University School of Medicine, Saint Louis, MO
3 shared publications - Ashutosh Kumar
Washington University
2 shared publications - John D. Tranter
Department of Internal Medicine, Cardiovascular Division (Q.Y., Y.Z., J.M., P.A., N.J., J.D.T., T.M.A.E.-A., M.R., R.S.), Washington University School of Medicine, Saint Louis, MO
2 shared publications - Nihil Abraham
Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
2 shared publications Ryan T. Mikami
Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
2 shared publications
Latest Publications
- Open Access
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadt6366
Lysosomal LRRC8 complex impacts lysosomal pH, morphology, and systemic glucose metabolism
The lysosome integrates anabolic signaling and nutrient sensing to regulate intracellular growth pathways. The leucine-rich repeat–containing 8 (LRRC8) channel complex forms a lysosomal anion channel and regulates PI3K-AKT-mTOR signaling, skeletal muscle differentiation, growth, and systemic glucose metabolism. Here, we define the endogenous LRRC8 subunits localized to a subset of lysosomes in differentiated myotubes. We show that LRRC8A affects leucine-stimulated mTOR; lysosome size; number; pH; expression of lysosomal proteins LAMP2, P62, and LC3B; and lysosomal function. Mutating an LRRC8A lysosomal targeting dileucine motif sequence (LRRC8A-L706A;L707A) in myotubes recapitulates the abnormal AKT signaling and altered lysosomal morphology and pH observed in LRRC8A knockout cells. In vivo, LRRC8A-L706A;L707A knock-in mice exhibit increased adiposity, impaired glucose tolerance and insulin resistance associated with reduced skeletal muscle PI3K-AKT-mTOR signaling, glucose uptake, and impaired incorporation of glucose into glycogen. These data reveal a lysosomal LRRC8-mediated metabolic signaling function regulating lysosomal function, systemic glucose homeostasis, and insulin sensitivity.
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadt6366
Open AccessLysosomal LRRC8 complex impacts lysosomal pH, morphology, and systemic glucose metabolism
The lysosome integrates anabolic signaling and nutrient sensing to regulate intracellular growth pathways. The leucine-rich repeat–containing 8 (LRRC8) channel complex forms a lysosomal anion channel and regulates PI3K-AKT-mTOR signaling, skeletal muscle differentiation, growth, and systemic glucose metabolism. Here, we define the endogenous LRRC8 subunits localized to a subset of lysosomes in differentiated myotubes. We show that LRRC8A affects leucine-stimulated mTOR; lysosome size; number; pH; expression of lysosomal proteins LAMP2, P62, and LC3B; and lysosomal function. Mutating an LRRC8A lysosomal targeting dileucine motif sequence (LRRC8A-L706A;L707A) in myotubes recapitulates the abnormal AKT signaling and altered lysosomal morphology and pH observed in LRRC8A knockout cells. In vivo, LRRC8A-L706A;L707A knock-in mice exhibit increased adiposity, impaired glucose tolerance and insulin resistance associated with reduced skeletal muscle PI3K-AKT-mTOR signaling, glucose uptake, and impaired incorporation of glucose into glycogen. These data reveal a lysosomal LRRC8-mediated metabolic signaling function regulating lysosomal function, systemic glucose homeostasis, and insulin sensitivity.
- Open Access
- 29 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (35) , eadw0424
Excitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels
Neuronal death in stroke and other conditions stems in part from stimulation of N -methyl- d -aspartate (NMDA)–type glutamate receptors. This induces neuronal production of both nitric oxide and superoxide, which together induce oxidative cell injury. Nitric oxide can readily cross lipid membranes, but superoxide, being an anion, cannot. Using primary neuronal cultures, we show that superoxide enters neurons through volume-regulated anion channels (VRACs). Oxidative injury produced by either exogenous superoxide or NMDA receptor stimulation is prevented by the VRAC inhibitor [4-(2-butyl-6,7-dichlor-2-cyclopentylindan-1-on-5-yl)oxybutyric acid] (DCPIB) and by disruption of the essential VRAC subunit, leucine-rich repeat–containing 8A (LRRC8A). In mouse cortex, neuronal oxidative injury induced by either NMDA or transient ischemia is likewise blocked by both DCPIB and LRRC8A disruption. Selective expression of LRRC8A/C and LRRC8A/E but not LRRC8A/D subunits conferred superoxide conductance in HeLa cells. Superoxide entry through VRACs is thus a requisite step in excitotoxic neuronal injury, and interventions affecting VRAC subunit composition, localization, or opening could influence neuronal survival.
- 29 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (35) , eadw0424
Open AccessExcitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels
Neuronal death in stroke and other conditions stems in part from stimulation of N -methyl- d -aspartate (NMDA)–type glutamate receptors. This induces neuronal production of both nitric oxide and superoxide, which together induce oxidative cell injury. Nitric oxide can readily cross lipid membranes, but superoxide, being an anion, cannot. Using primary neuronal cultures, we show that superoxide enters neurons through volume-regulated anion channels (VRACs). Oxidative injury produced by either exogenous superoxide or NMDA receptor stimulation is prevented by the VRAC inhibitor [4-(2-butyl-6,7-dichlor-2-cyclopentylindan-1-on-5-yl)oxybutyric acid] (DCPIB) and by disruption of the essential VRAC subunit, leucine-rich repeat–containing 8A (LRRC8A). In mouse cortex, neuronal oxidative injury induced by either NMDA or transient ischemia is likewise blocked by both DCPIB and LRRC8A disruption. Selective expression of LRRC8A/C and LRRC8A/E but not LRRC8A/D subunits conferred superoxide conductance in HeLa cells. Superoxide entry through VRACs is thus a requisite step in excitotoxic neuronal injury, and interventions affecting VRAC subunit composition, localization, or opening could influence neuronal survival.
- Open Access
- 28 August 2025
- Published by American Society of Hematology in Blood
- Vol. 146 (9) , 1110-1126
LRRC8 complexes are ATP release channels that regulate platelet activation and arterial thrombosis
Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in leucine-rich repeat–containing 8 (LRRC8) protein subunits that form the volume-regulated anion channel (VRAC), which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume; adhesion; and agonist-stimulated activation, aggregation, adenosine triphosphate (ATP) secretion, and calcium mobilization. MK-specific LRRC8A conditional knockout mice have reduced laser injury–induced cremaster arteriolar thrombus formation and prolonged FeCl3 induced carotid arterial thrombosis without prolonged bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced cytosolic ATP release to amplify agonist-stimulated calcium–phosphoinositide 3-kinase–protein kinase B signaling. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP release channel in platelets, which positively regulates platelet function and thrombosis, providing a proof of concept for a novel antithrombotic drug target.
- 28 August 2025
- Published by American Society of Hematology in Blood
- Vol. 146 (9) , 1110-1126
Open AccessLRRC8 complexes are ATP release channels that regulate platelet activation and arterial thrombosis
Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in leucine-rich repeat–containing 8 (LRRC8) protein subunits that form the volume-regulated anion channel (VRAC), which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume; adhesion; and agonist-stimulated activation, aggregation, adenosine triphosphate (ATP) secretion, and calcium mobilization. MK-specific LRRC8A conditional knockout mice have reduced laser injury–induced cremaster arteriolar thrombus formation and prolonged FeCl3 induced carotid arterial thrombosis without prolonged bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced cytosolic ATP release to amplify agonist-stimulated calcium–phosphoinositide 3-kinase–protein kinase B signaling. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP release channel in platelets, which positively regulates platelet function and thrombosis, providing a proof of concept for a novel antithrombotic drug target.